Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001013594-25-000395·Indivior Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
INDIVIOR PLC
Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") · CUSIP: G4766E116
Event date: 2025-03-11
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Madison Avenue International LP
Shares: 7,438,153 · Class: 6%
- Madison Avenue Partners, LP
Shares: 7,438,153 · Class: 6%
- EMAI Management, LLC
Shares: 7,438,153 · Class: 6%
- Madison Avenue GP, LLC
Shares: 7,438,153 · Class: 6%
- Caraway Jackson Investments LLC
Shares: 7,438,153 · Class: 6%
- Eli Samaha
Shares: 7,438,153 · Class: 6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-25-000395
- Form type
- SCHEDULE 13G
- Filer
- Indivior Pharmaceuticals, Inc.
- CIK
- CIK 1625297
- Filed
- Mar 18, 2025
- Reporting period
- Mar 11, 2025
- Description
- Schedule 13G beneficial ownership